Novavax Hopes COVID-19/Flu Vaccine Combo Can Help It Keep Up With mRNA Leaders

But COVID-19 Component Not Updated

 
• By Andrew McConaghie

Novavax recently slashed its revenues forecasts, but is hoping a two-in-one COVID-19 and flu combination could help it carve out space in the post-pandemic market.

Novavax
Novavax reached the market too late to make a big impression, but wants to stake a claim in the post-pandemic market with a combined covid and flu jab. • Source: Shutterstock

More from Business

More from Scrip